EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.

Summary The harmful use of alcohol has been estimated to cause approximately 3.3 million deaths every year, corresponding to nearly 6% of all deaths globally. Therefore, the effective management and treatment of alcoholic liver disease is a pertinent public health issue. In the following Clinical Practice Guidelines, the latest data on the treatment and management of alcohol-related liver disease will be reviewed and up to date recommendations for clinical management will be provided.

• Publication year

  2018

• Venue

  Journal of Hepatology

• Publication date

  2018-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jhep.2018.03.018PMID 29628280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.

  2018cited by this paper
• Alcohol consumption among adults

  2018cited by this paper
• Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis

  2018cited by this paper
• [Alcoholic hepatitis].

  2018cited by this paper
• Alcohol and Cancer: A Statement of the American Society of Clinical Oncology.

  2018cited by this paper
• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

  2018cited by this paper
• Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis

  2017cited by this paper
• Self-management and Shared Decision-Making in Alcohol Dependence via a Mobile App: a Pilot Study

  2017cited by this paper
• Caspase‐cleaved keratin‐18 fragments increase during alcohol withdrawal and predict liver‐related death in patients with alcoholic liver disease

  2017cited by this paper
• Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study

  2017cited by this paper
• Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?

  2017cited by this paper
• Sepsis in alcohol-related liver disease.

  2017cited by this paper
• Transient elastography alone and in combination with FibroTest® for the diagnosis of hepatic fibrosis in alcoholic liver disease

  2017cited by this paper
• Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study

  2017cited by this paper
• A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis

  2017cited by this paper
• Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.

  2017cited by this paper
• A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients—The ALPADIR Study

  2017cited by this paper
• Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers

  2017cited by this paper
• The relationship between different dimensions of alcohol use and the burden of disease—an update

  2017cited by this paper
• Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.

  2017cited by this paper
• Effect of alcohol consumption on all‐cause and liver‐related mortality among HIV‐infected individuals

  2017cited by this paper
• Pathophysiology and Management of Alcoholic Liver Disease: Update 2016

  2017cited by this paper
• The genetics of alcohol dependence and alcohol-related liver disease.

  2017cited by this paper
• Binge drinking and the risk of liver events: A population‐based cohort study

  2017cited by this paper
• Role of Zinc in the Development/Progression of Alcoholic Liver Disease

  2017cited by this paper
• American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.

  2017cited by this paper
• Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.

  2017cited by this paper
• Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease.

  2017cited by this paper
• The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial

  2017cited by this paper
• Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study

  2017cited by this paper
• Reprint of Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT).

  2017cited by this paper
• In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA

  2017cited by this paper
• Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease.

  2017cited by this paper
• Hepatitis B virus infection and alcohol consumption

  2017cited by this paper
• Acute-on-chronic liver failure: an update

  2017cited by this paper
• Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate

  2017cited by this paper
• Alcohol withdrawal syndrome: mechanisms, manifestations, and management

  2016cited by this paper
• A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications?

  2016cited by this paper
• Alcohol and liver disease in Europe--Simple measures have the potential to prevent tens of thousands of premature deaths.

  2016cited by this paper
• Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist?

  2016cited by this paper
• Alcoholic liver disease and hepatitis C virus infection.

  2016cited by this paper
• Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.

  2016cited by this paper
• Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996–2013

  2016cited by this paper
• EASL Clinical Practice Guidelines: Liver transplantation.

  2016cited by this paper
• Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.

  2016cited by this paper
• How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?

  2016cited by this paper
• Alcohol consumption and risk of infection after a variceal bleeding in low‐risk patients

  2016cited by this paper
• Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta‐analysis of randomized trials

  2016cited by this paper
• Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.

  2016cited by this paper
• Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis.

  2016cited by this paper
• The clinical course of alcoholic cirrhosis: development of comorbid diseases. A Danish nationwide cohort study

  2016cited by this paper
• In alcoholic cirrhosis, low‐serum hepcidin levels associate with poor long‐term survival

  2016cited by this paper
• Liver transplantation in Germany

  2016cited by this paper
• Nutrition and Alcoholic Liver Disease: Effects of Alcoholism on Nutrition, Effects of Nutrition on Alcoholic Liver Disease, and Nutritional Therapies for Alcoholic Liver Disease.

  2016cited by this paper
• Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study1[S]

  2016cited by this paper
• Alcohol Use Disorders in Primary Health Care: What Do We Know and Where Do We Go?

  2016cited by this paper
• Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States—A Single‐Center Experience

  2016cited by this paper
• Paper alert.

  2016cited by this paper
• Biomarker-Based Approaches for Assessing Alcohol Use Disorders

  2016cited by this paper
• Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.

  2016cited by this paper
• Levels of Hair Ethyl Glucuronide in Patients with Decreased Kidney Function: Possibility of Misclassification of Social Drinkers.

  2016cited by this paper
• Liver Fibrosis in Alcoholic Liver Disease

  2015cited by this paper
• Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study.

  2015cited by this paper
• PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease

  2015cited by this paper
• Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease

  2015cited by this paper
• Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.

  2015cited by this paper
• The role of iron in alcohol-mediated hepatocarcinogenesis.

  2015cited by this paper
• Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension

  2015cited by this paper
• Alcoholic liver disease: the gut microbiome and liver cross talk.

  2015cited by this paper
• Alcoholic liver disease: Clinical and translational research.

  2015cited by this paper
• Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study

  2015cited by this paper
• Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III.

  2015cited by this paper
• Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.

  2015cited by this paper
• Alcoholic liver disease: mechanisms of injury and targeted treatment

  2015cited by this paper
• Prednisolone or pentoxifylline for alcoholic hepatitis.

  2015cited by this paper
• Alcohol and cardiovascular diseases: where do we stand today?

  2015cited by this paper
• Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors

  2015cited by this paper
• Identification and Management of Alcohol Withdrawal Syndrome

  2015cited by this paper
• Liver transplantation for alcoholic hepatitis: A survey of liver transplant centers

  2015cited by this paper
• Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis

  2015cited by this paper
• Determination of direct alcohol markers: a review

  2015cited by this paper
• Alcoholic liver disease - the extent of the problem and what you can do about it.

  2015cited by this paper
• Influence of repeated permanent coloring and bleaching on ethyl glucuronide concentrations in hair from alcohol-dependent patients.

  2015cited by this paper
• Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol‐related acute‐on‐chronic liver failure

  2015cited by this paper
• Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

  2015cited by this paper
• The use of beta‐blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis

  2015cited by this paper
• Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.

  2015cited by this paper
• The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.

  2015cited by this paper
• Predicting Liver Transplant Capacity Using Discrete Event Simulation

  2015cited by this paper
• Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta‐analysis

  2015cited by this paper
• Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis.

  2015cited by this paper
• Bacterial infections in alcoholic and nonalcoholic liver cirrhosis

  2015cited by this paper
• High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.

  2015cited by this paper
• Declining liver graft quality threatens the future of liver transplantation in the United States

  2015cited by this paper
• Ethnic differences in presentation and severity of alcoholic liver disease.

  2015cited by this paper
• Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder.

  2014cited by this paper
• A histologic scoring system for prognosis of patients with alcoholic hepatitis.

  2014cited by this paper
• Invasive aspergillosis in patients with severe alcoholic hepatitis.

  2014cited by this paper
• Diagnosis of alcoholic liver disease.

  2014cited by this paper
• Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?

  2014cited by this paper

• Mechanism of action of postbiotics intervention in alcoholic liver injury and future research directions

  2026cites this paper
• MyWayUp: A Digital Intervention for Alcohol Use Disorder in Patients With Alcohol‐Related Liver Disease—Results From an RCT

  2026cites this paper
• Enhancing care in alcohol-associated liver disease through peer support for alcohol use disorder

  2026cites this paper
• Metabolic and liver stiffness measures for hepatocellular carcinoma risk stratification after viral eradication in chronic hepatitis C.

  2026cites this paper
• Interleukin-38: A Candidate Biomarker for Disease Severity in Advanced Steatotic Liver Disease

  2026cites this paper
• Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF).

  2026cites this paper
• Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management☆

  2026cites this paper
• Recompensation following first decompensation in patients with alcohol-related cirrhosis

  2026cites this paper
• Practical Guide to Best Practices in Alcohol-Associated Liver Disease

  2026cites this paper
• Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy

  2026cites this paper
• Impact of metabolic syndrome components on fibrosis severity and mortality in alcohol-related liver disease.

  2026cites this paper
• Holiday-associated biochemical patterns of pancreatitis: a 16-year retrospective analysis of ambulatory laboratory data (2009–2024)

  2026cites this paper
• TFR2 p.A75V mutation aggravates liver iron overload in alcoholic liver disease via ERK pathway

  2026cites this paper
• Efficacy of Combined Plasma Exchange With Plasma Adsorption/Hemoperfusion Artificial Liver Support System (ALSS) in Treating Acute‐on‐Chronic Liver Failure due to Hepatitis B

  2026cites this paper
• Herb-Induced Liver Injury by Laurus nobilis: A Case Assessed for Causality Using the Updated RUCAM

  2026cites this paper
• Interpreting fibrosis markers in psychoactive substance use disorders: Key confounders to consider.

  2026cites this paper
• Molecular Mechanistic Pathways Targeted by Natural Products in the Prevention and Treatment of Alcoholic Liver Disease

  2026cites this paper
• Radiological Insights into Alcohol Use Associated Disorders and Diseases: Part I

  2026cites this paper
• Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations

  2025cites this paper
• Integrated Alcohol Use Disorder and Liver Disease Management

  2025cites this paper
• Interpreting abnormal liver blood test results

  2025cites this paper
• Metabolomics in the study of alcohol use disorder: a systematic review.

  2025cites this paper
• Non-invasive tests for MetALD and alcohol-related liver disease

  2025cites this paper
• Global, regional, and national burdens of cirrhosis in childhood and adolescence during 2000 to 2021: an age-period-cohort analysis

  2025cites this paper
• Models of care for the management of cirrhosis: a global review

  2025cites this paper
• Alcohol Use Disorder: Natural History, Definitions, and Stigma.

  2025cites this paper
• Usefulness of Gamma-Glutamyl Transferase and Sequential Carbohydrate-Deficient Transferrin for Unhealthy Alcohol Use Screening in Indigenous Communities.

  2025cites this paper
• Low Alanine Aminotransferase Levels in Alcohol Consuming Male Subjects, Carriers of the Common ALDH2 Deficient Variant, ALDH2*2

  2025cites this paper
• Ethanol-induced liver injury is alleviated by chrysin via increasing MRP2 transporter expression and enhancing the Nrf2-mediated adaptive response.

  2025cites this paper
• Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol-free and low-alcohol products in higher risk groups.

  2025cites this paper
• Cognitive Performance in Patients With Alcohol-Associated Liver Disease Undergoing Liver Transplantation

  2025cites this paper
• Alcohol-related liver disease

  2025cites this paper
• Met-ALD and ALD- Does Differentiating These Impact Management and Clinical Outcomes?

  2025cites this paper
• Gene Therapy for Hemophilias: Opportunities and Challenges for the Clinical Laboratory.

  2025cites this paper
• Phosphatidylethanol in steatotic liver disease.

  2025cites this paper
• A novel Kupffer cell-targeting nanoparticle system to Mitigate alcohol-associated liver disease

  2025cites this paper
• Alcoholic liver disease as a global health problem: Pathogenesis, diagnosis, and modern treatment approaches

  2025cites this paper
• Alcoholic Hepatitis in a Japanese Hospital: Losing Contact With Some Patients After Delirium Tremens May Lead to Missed Critical Events

  2025cites this paper
• Management of alcohol use disorder in alcohol-related liver disease

  2025cites this paper
• Public health policies to prevent alcohol-related liver disease

  2025cites this paper
• Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-analysis.

  2025cites this paper
• Prognostic value of early Lille score in patients with severe alcohol-associated hepatitis.

  2025cites this paper
• Diabetes mellitus in alcohol-associated liver disease: Prevalence and outcomes

  2025cites this paper
• Assessing Efficacy of Interleukin-1 Blockade in Patients with Alcoholic Hepatitis: A Comprehensive Systematic Review of Emerging Evidence

  2025cites this paper
• The hepatic and developmental toxicity of chronic morphine and disulfiram co-treatment for pain relief - a comprehensive in vitro and in vivo assessment.

  2025cites this paper
• Safety and efficacy of probiotics in the treatment of ALD

  2025cites this paper
• Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction–Associated Steatotic Liver Disease

  2025influential citation
• Risk of alcohol-related liver disease and cause-specific mortality in individuals seeking treatment for alcohol use disorder.

  2025cites this paper
• Low incidence of cytolysin-positive E. faecalis and no correlation to survival in Danish patients with alcohol-associated hepatitis: A prospective cohort study

  2025cites this paper
• Effect of Nutraceutical Supplementation and Mediterranean Hypocaloric Diet on Calculated Steatosis Indices and Inflammation: Clinical and In Vitro Evidences

  2025cites this paper
• Early liver transplantation in Alcohol-Associated liver disease - evolution of practice, patient selection, management & outcomes.

  2025cites this paper
• Reducing alcohol-associated liver disease burden in the general population.

  2025cites this paper
• Beyond corticosteroids: A systematic review of novel therapeutic strategies in severe alcoholic hepatitis and 90-day survival

  2025cites this paper
• Life after hepatorenal syndrome: unraveling quality of life, psychological distress, and treatment preferences

  2025influential citation
• Medical Treatments and Outcomes in Acute Alcohol-Related Hepatitis.

  2025cites this paper
• Binge drinking acutely induces hepatic steatosis which is readily reversible: A real-world observational study in healthy adults

  2025cites this paper
• Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Neonatal Liver-Derived Extracellular Vesicle: Unlocking Mitochondrial Repair and Regenerative Mechanisms in Alcoholic Liver Disease.

  2025cites this paper
• Therapeutic Options for Alcohol-Associated Hepatitis in Resource-Limited Settings

  2025cites this paper
• The Liver Care Trial: screening for liver disease in individuals attending treatment for alcohol use disorder—study protocol for a randomized controlled study

  2025influential citation
• Anti-Inflammatory Drugs for Alcoholic Liver Disease: A Systematic Review on Survival and Adverse Events

  2025cites this paper
• Liver-Related COVID-19 Consequences: Dynamics of Liver Health in 2.5 Years

  2025cites this paper
• Alcohol Consumption After Listing for Liver Transplantation Is Associated With Increased Risk of Alcohol Consumption After Transplantation

  2025cites this paper
• Initial Experience With Nalmefene in Alcohol‐Related Liver Disease: A Real‐World Retrospective Study

  2025cites this paper
• Phosphatidylethanol and ethyl glucuronide to categorize alcohol consumption in alcohol-related cirrhosis

  2025cites this paper
• Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver Transplantation.

  2025cites this paper
• Development and evaluation of percentile curves of serum alanine aminotransferase in older adults: A multi-cohort study.

  2025cites this paper
• Infections in Standard or Tapered Dose of Prednisolone for Alcohol-Associated Hepatitis: A Randomized Trial (STASH Trial).

  2025cites this paper
• Dependencia del alcohol

  2025cites this paper
• Noninvasive Quantification of Hepatic Steatosis Using Ultrasound‐Derived Fat Fraction (CHESS2303): A Prospective Multicenter Study

  2025cites this paper
• Biomarkers for Harmful Alcohol Use should be Reliable, Standardised, and Traceable

  2025cites this paper
• Vine tea (Ampelopsis grossedentata) ameliorates chronic alcohol-induced hepatic steatosis, oxidative stress, and inflammation via YTHDF2/PGC-1α/SIRT3 axis.

  2025cites this paper
• S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion

  2025cites this paper
• Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023

  2025cites this paper
• Monitoring and treatment of alcohol use disorder: an integrated multidisciplinary model.

  2025cites this paper
• Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2

  2025cites this paper
• Latest Insights in Alcohol-Related Liver Disease and Alcoholic Hepatitis

  2025cites this paper
• Decompensated cirrhosis: an update of the BSG/BASL admission care bundle

  2025cites this paper
• Current insights into pathogenesis and anti‐inflammatory treatment strategies for severe alcohol‐associated hepatitis: focus on neutrophil‐targeted therapies

  2025influential citation
• Under the Influence: The Epidemic of Excessive Alcohol Use and Its Impact on Heart and Liver Health.

  2025cites this paper
• Acute alcoholis hepatitis

  2025cites this paper
• Impact of alcohol consumption on nature of nutrition, metabolism and human target organs. Part 3. The role and significance of micronutrients

  2025cites this paper
• [Alcohol treatment for patients with alcohol-related liver disease].

  2025cites this paper
• Targeting gut health: Probiotics as promising therapeutics in alcohol-related liver disease management

  2025cites this paper
• Liver biopsy and acute hepatology in intensive care unit patients

  2025influential citation
• Carbohydrate‐Deficient Transferrin Evaluation Over Time Has Usefulness for Confirming Sobriety of Alcohol Rehabilitation Program Patients

  2025cites this paper
• Pharmacologic modulation of systemic inorganic phosphate levels restores the impaired phagocytosis of Kupffer cells and improves liver function in murine models of chronic liver failure.

  2025cites this paper
• Alcohol Consumption Behaviors and Liver Disease: Is There a Safer Drinking Practices?

  2025cites this paper
• Steatotic liver disease: what role does alcohol consumption play?

  2025cites this paper
• Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond.

  2025cites this paper
• Serum β-klotho is a potential biomarker for diagnosing alcoholic liver disease and differentiating from nonalcoholic fatty liver disease

  2025cites this paper
• Nanomedicines in the Treatment of Liver Fibrosis: A Review

  2025cites this paper
• Management of asymptomatic patients with abnormal liver function tests.

  2025cites this paper
• Mildly elevated liver lipid content is characterised by reduced insulin sensitivity

  2025cites this paper
• New Approaches to Alcohol-Associated Hepatitis.

  2025cites this paper
• Patterns and Outcomes of Alcoholic Liver Disease (ALD) in Oman: A Retrospective Study in a Culturally Conservative Context

  2025cites this paper
• Weizmannia coagulans BC179 Alleviates Post-Alcohol Discomfort May via Taurine-Related Metabolism and Antioxidant Regulation: A Randomized, Double-Blind, Placebo-Controlled Trial

  2025cites this paper
• Insights on Alcohol-Associated Liver Disease, a Decade of Data from National Survey

  2025cites this paper
• Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure

  2025cites this paper
• Hepatocellular carcinoma in people living with HIV.

  2025cites this paper